TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
JANX

Janux Therapeutics Inc

Healthcare · Biotechnology

17.00$ +2.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JANX
Line item 2019 2020 2021 2022 2023 2024 2025
+2,288.4% +2,242.1% -4.2% +4.5% +179.0% -5.1%
+2,341.0% +2,247.3% -11.8% +5.1% +196.0% -5.6%
+1,087.4% +355.4% +44.5% -62.7% +2,142.2% -87.8%
+1,087.4% +4,699.2% -12.8% +5.2% +198.0% -5.7%
-97.5% +250.0% +214.3% +144.6% +19.5%
+638.1% +930.3% +343.7%
+257.8% -56.3% +220.6% -16.7% +7.4% +30.9%
-31.3% +302.3% +29.0% -21.0% +34.0% +43.2%
-81.2% -74.2% +293.3% +98.8% +15.3% +36.8%
+60.3% +474.3% -12.2% +12.3% +66.1% +23.5%
-12.4% +7.4% +197.0% -6.4%
+0.0% -0.9% +0.5% +6.1% +22.1% +15.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?